When was Bilcare founded?

Bilcare was founded in 1993 and raised its 1st funding round 17 years after it was founded.

Where is Bilcare located?

Bilcare is headquartered in Pune, India. It is registered at 1028 Shiroli, Rajgurunagar, Pune, Shiroli, Pune, Khed, Maharashtra, India, 410505.

Who is the current CEO of Bilcare?

Mohan Bhandari of Bilcare. They have also founded 1 company.

How many employees does Bilcare have?

As of May 31, 2026, the latest employee count at Bilcare is 286.

Is Bilcare a funded company?

Bilcare is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Feb 22, 2010.

When was the latest funding round of Bilcare?

Bilcare's latest funding was a $***** Conventional Debt round on Aug 27, 2014, with participation from 1 investor.

What is the annual revenue of Bilcare?

Annual revenue of Bilcare is between ₹500 Cr and ₹1,000 Cr as on Mar 31, 2025

Where does Bilcare rank among its competitors?

Bilcare ranks 68th amongst 876 active competitors, of which 27 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Nivagen Pharmaceuticals, which secured $5M in Aug, 2023.

Who are the top competitors of Bilcare?

Bilcare's top competitors include Jubilant Life Sciences, Akums and Nivagen Pharmaceuticals. Among them, Nivagen Pharmaceuticals secured the most recent funding round in August, 2023.

Bilcare - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Bilcare is a pharma packaging solutions provider. The company has 3 major divisions - Pharmaceutical Packaging International (PPI), Global Clinical Material Supplies (GCS) and non-clonable ID technologies. The PPI division offers packaging solutions mainly for solid dose packaging through specialty Polymer Films and Aluminum Foils. The GCS division offers clinical trial supply management services such as clinical supplies packaging and labelling, controlled-temperature (cold chain) CTM storage, worldwide distribution and returns and destructions accountability etc. The non-clonable ID technologies division offers track and trace, authentication and Anti-counterfeit (trademarked nCID technology - nonclonableID) solutions for product; people ID authentication and security. The company has 9 manufacturing facilities spread across Europe, US and Asia. Bilcare's clientele includes Bristol-Myers Squibb, Dr. Reddy’s, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Ranbaxy, Sanofi-Aventis, and Teva, among others.

Website: bilcare.com
Social
Email ID: *****@bilcare.com
Phone Number: +91 **********
Registered Address: 1028 Shiroli, Rajgurunagar, Pune, Shiroli, Pune, Khed, Maharashtra, India, 410505

Key Metrics

Founded Year

1993

Location

Pune, India

Stage

Acquired

Latest Funding Round

Conventional Debt, Aug 27, 2014, $*****

Investors

Rare Enterprises & 2 more

Ranked

68^th among 876 active competitors

Annual Revenue

₹500 - ₹1,000 Cr as on Mar 31, 2025

Employee Count

286 as on May 31, 2026

Investment & Acquisitions

Singular ID

Similar Companies

Jubilant Life Sciences & 1088 more

Exit Details

Acquired by Lindsay Goldberg (Sep 04, 2019)

View Bilcare's full profile

Bilcare is associated with 4 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BILCARE GCS LIMITED CIN: 9521655 , United Kingdom, Active	Mar 31, 2015	$0 - $1M (As on Mar 31, 2022)	-
BILCARE RESEARCH, INC. CIN: 383655283 , United States, Active	Dec 31, 1999	-	68 (As on Dec 31, 2024)	-
CAPRIHANS INDIA LIMITED CIN: L29150PN1946PLC232362 , India, Active	Apr 11, 1946	$50M - $100M (As on Mar 31, 2025)	505 (As on Apr 30, 2025)
BILCARE LIMITED CIN: L28939PN1987PLC043953 , India, Active	Jul 01, 1987	$50M - $100M (As on Mar 31, 2025)	75 (As on Nov 30, 2024)

Bilcare got acquired by Lindsay Goldberg on Sep 04, 2019.

Click here to take a look at Bilcare's acquisition in detail

Bilcare has raised funding over 2 rounds. Its first funding round was on Feb 22, 2010. Its latest funding round was a Conventional Debt round on Aug 27, 2014 for $*****. 1 investor participated in its latest round. Bilcare has 3 institutional investors.

Here is the list of recent funding rounds of Bilcare:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 27, 2014	3924873	Conventional Debt	1674854	2811591	7645184	9939453
Feb 22, 2010	6052459	Post IPO	2804117	9368711	6443548	ISM Capital

Access funding benchmarks and valuations. Sign up today!

View details of Bilcare's funding rounds and investors

The founders of Bilcare are Mohan Bhandari and Wolfgang Beck. Mohan Bhandari is the CEO of Bilcare.

Here are the details of Bilcare's key team members:

Mohan Bhandari: Founder & CEO of Bilcare. They serve on the board of 1 company.
Contact Info: 1 email address
Wolfgang Beck: Founder of Bilcare.

Bilcare's Board of Directors

Bilcare's board has 6 active members. Mohan Bhandari is part of team and Kavita Bhansali, Rajesh Shankarrao Devene, Abhigyan Upadhyay, Alka Sagar and Madhuri Rajan Vaidya are independent board members.

Here is the list of Bilcare's board of directors:

Name	Type	Representing	Status	Duration
Mohan Bhandari	Team	-	Current	3y 10m
Kavita Bhansali	Independent board member	-	Current	2y 9m
obfxa{w	Independent board member	-	Current	9y 3m
iwpwlgw	Independent board member	-	Current	5y 4m
imtisdy	Independent board member	-	Current	1y 4m
s{czpgf	Independent board member	-	Current	6y 9m

View details of Bilcare's Founder profiles and Board Members

Bilcare's employee count trend

Bilcare has 286 employees as of May 26. Here is Bilcare's employee count trend over the years:

Uncover Bilcare's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Bilcare include Jubilant Life Sciences, Akums and Nivagen Pharmaceuticals. Here is the list of Top 10 competitors of Bilcare, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jubilant Life Sciences 1978, Noida (India), Public	Company offering a suite of R&D and manufacturing services for small molecules and generics	-	Samena Capital, General Atlantic & 1 others	59/100
2nd	Akums 2004, Delhi (India), Public	CDMO focusing on spectrum of dosage forms and therapeutic segments	$70M	Quadria Capital & 5 others	58/100
3rd	Nivagen Pharmaceuticals 2009, Sacramento (United States), Acquired	Developer and contract manufacturer of generic drugs, tablets, capsules, ointment and solution	$31M	Telegraph Hill Partners, BizCap & 1 others	57/100
4th	SAVA group 2003, Pune (India), Unfunded	Pharma company with a portfolio of domestic and export products, also offering CRAMS services	-	-	56/100
5th	Nectar Lifesciences 1995, Chandigarh (India), Public	Manufacturer of cephalosporin APIs and generic formulations	$46.9M	Vedanta Capital, NSR Partners & 1 others	55/100
6th	Recipharm 1995, Jordbro (Sweden), Acquired	Contract services for pharmaceutical development and manufacturing	-	Ampersand Capital, CPP Investments	55/100
7th	Supriya Lifescience 2008, Mumbai (India), Public	Manufacturer of active pharmaceutical ingredients and finished dosage formulations for healthcare	-	-	54/100
8th	Chugai Pharmaceutical 1925, Tokyo (Japan), Acquired	Developer of innovative pharmaceutical products and services	-	Digital Pharma Lab	54/100
9th	Asahi Kasei 1931, Chiyoda-ku (Japan), Public	CDMO focused on manufacturing of liquid, solid & injectable drug formulations	-	Europa	53/100
10th	Alliance 1998, Chippenham (United Kingdom), Public	International consumer healthcare business managing brands and partnerships	-	Eiffel Investment Group, Artemis Investment Management ... & 2 others	51/100
68th	Bilcare 1993, Pune (India), Acquired	Company offering innovative solutions for pharma packaging, clinical supplies and anti-counterfeiting	-	Rare Enterprises, Proventus & 1 others	41/100